vs
TRANSACT TECHNOLOGIES INC（TACT）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是TRANSACT TECHNOLOGIES INC的1.2倍（$13.2M vs $11.5M），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 11.9%），TRANSACT TECHNOLOGIES INC自由现金流更多（$589.0K vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 3.5%）
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
TACT vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.2倍
$11.5M
营收增速更快
TLSI
高出47.9%
11.9%
自由现金流更多
TACT
多$3.1M
$-2.5M
两年增速更快
TLSI
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5M | $13.2M |
| 净利润 | — | $-9.8M |
| 毛利率 | 47.6% | 86.7% |
| 营业利润率 | -10.1% | -24.8% |
| 净利率 | — | -73.9% |
| 营收同比 | 11.9% | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-0.11 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TACTTLSI
| Q4 25 | $11.5M | $13.2M | ||
| Q3 25 | $13.2M | $11.6M | ||
| Q2 25 | $13.8M | $11.2M | ||
| Q1 25 | $13.1M | $9.2M | ||
| Q4 24 | $10.2M | $8.3M | ||
| Q3 24 | $10.9M | $7.3M | ||
| Q2 24 | $11.6M | $7.4M | ||
| Q1 24 | $10.7M | $6.5M |
净利润TACTTLSI
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $15.0K | $-10.8M | ||
| Q2 25 | $-143.0K | $-8.3M | ||
| Q1 25 | $19.0K | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $-551.0K | $-2.4M | ||
| Q2 24 | $-319.0K | $-4.3M | ||
| Q1 24 | $-1.0M | $-13.2M |
毛利率TACTTLSI
| Q4 25 | 47.6% | 86.7% | ||
| Q3 25 | 49.8% | 83.5% | ||
| Q2 25 | 48.2% | 83.9% | ||
| Q1 25 | 48.7% | 83.7% | ||
| Q4 24 | 44.2% | 85.3% | ||
| Q3 24 | 48.1% | 86.3% | ||
| Q2 24 | 52.7% | 87.6% | ||
| Q1 24 | 52.6% | 85.0% |
营业利润率TACTTLSI
| Q4 25 | -10.1% | -24.8% | ||
| Q3 25 | 0.1% | -77.9% | ||
| Q2 25 | -1.9% | -65.4% | ||
| Q1 25 | -0.1% | -79.9% | ||
| Q4 24 | -10.3% | -91.8% | ||
| Q3 24 | -7.7% | -118.9% | ||
| Q2 24 | -3.8% | -111.0% | ||
| Q1 24 | -12.2% | -180.8% |
净利率TACTTLSI
| Q4 25 | — | -73.9% | ||
| Q3 25 | 0.1% | -93.5% | ||
| Q2 25 | -1.0% | -73.9% | ||
| Q1 25 | 0.1% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | -5.1% | -32.6% | ||
| Q2 24 | -2.8% | -58.8% | ||
| Q1 24 | -9.7% | -204.5% |
每股收益（稀释后）TACTTLSI
| Q4 25 | $-0.11 | $-0.22 | ||
| Q3 25 | $0.00 | $-0.96 | ||
| Q2 25 | $-0.01 | $-0.27 | ||
| Q1 25 | $0.00 | $-0.39 | ||
| Q4 24 | $-0.80 | $-0.38 | ||
| Q3 24 | $-0.06 | $-0.12 | ||
| Q2 24 | $-0.03 | $-0.21 | ||
| Q1 24 | $-0.10 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.4M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $31.1M | $-33.9M |
| 总资产 | $44.8M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TACTTLSI
| Q4 25 | $20.4M | $20.4M | ||
| Q3 25 | $20.0M | $22.7M | ||
| Q2 25 | $17.7M | $26.5M | ||
| Q1 25 | $14.2M | $13.0M | ||
| Q4 24 | $14.4M | $8.5M | ||
| Q3 24 | $11.3M | $11.3M | ||
| Q2 24 | $11.1M | $16.5M | ||
| Q1 24 | $10.6M | $4.0M |
股东权益TACTTLSI
| Q4 25 | $31.1M | $-33.9M | ||
| Q3 25 | $31.8M | $-26.7M | ||
| Q2 25 | $31.3M | $-19.4M | ||
| Q1 25 | $30.9M | $-34.4M | ||
| Q4 24 | $30.6M | $-25.9M | ||
| Q3 24 | $38.4M | $-20.4M | ||
| Q2 24 | $38.5M | $-25.3M | ||
| Q1 24 | $38.6M | $-36.0M |
总资产TACTTLSI
| Q4 25 | $44.8M | $35.3M | ||
| Q3 25 | $45.0M | $36.5M | ||
| Q2 25 | $44.5M | $41.3M | ||
| Q1 25 | $44.2M | $28.6M | ||
| Q4 24 | $44.0M | $24.0M | ||
| Q3 24 | $50.5M | $27.5M | ||
| Q2 24 | $50.4M | $32.4M | ||
| Q1 24 | $51.9M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $609.0K | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $589.0K | $-2.5M |
| 自由现金流率自由现金流/营收 | 5.1% | -19.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.6M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流TACTTLSI
| Q4 25 | $609.0K | $-2.5M | ||
| Q3 25 | $3.6M | $-3.7M | ||
| Q2 25 | $3.6M | $-7.3M | ||
| Q1 25 | $-161.0K | $-4.5M | ||
| Q4 24 | $2.4M | $-5.7M | ||
| Q3 24 | $327.0K | $-10.8M | ||
| Q2 24 | $636.0K | $-13.4M | ||
| Q1 24 | $-1.5M | $-10.9M |
自由现金流TACTTLSI
| Q4 25 | $589.0K | $-2.5M | ||
| Q3 25 | $3.6M | $-3.9M | ||
| Q2 25 | $3.6M | $-7.4M | ||
| Q1 25 | $-171.0K | $-5.3M | ||
| Q4 24 | $2.4M | $-5.8M | ||
| Q3 24 | $259.0K | $-11.0M | ||
| Q2 24 | $499.0K | $-13.5M | ||
| Q1 24 | $-1.6M | $-10.9M |
自由现金流率TACTTLSI
| Q4 25 | 5.1% | -19.1% | ||
| Q3 25 | 27.1% | -33.9% | ||
| Q2 25 | 25.9% | -66.1% | ||
| Q1 25 | -1.3% | -57.3% | ||
| Q4 24 | 23.2% | -69.7% | ||
| Q3 24 | 2.4% | -149.9% | ||
| Q2 24 | 4.3% | -183.1% | ||
| Q1 24 | -14.9% | -169.3% |
资本支出强度TACTTLSI
| Q4 25 | 0.2% | 0.3% | ||
| Q3 25 | 0.5% | 1.9% | ||
| Q2 25 | 0.1% | 0.8% | ||
| Q1 25 | 0.1% | 8.2% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.6% | 2.3% | ||
| Q2 24 | 1.2% | 0.8% | ||
| Q1 24 | 1.0% | 1.0% |
现金转化率TACTTLSI
| Q4 25 | — | — | ||
| Q3 25 | 242.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -8.47× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
